1-11 of 11
Waleed Sabry
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mosunetuzumab Plus Polatuzumab Vedotin Demonstrates a Favorable Safety Profile and Efficacy in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Primary Analysis of a Phase Ib/II Study

L. Elizabeth Budde, Adam J Olszewski, Sarit Assouline, Izidore S. Lossos, Catherine Diefenbach, Manali Kamdar, Nilanjan Ghosh, Dipenkumar Modi, Waleed Sabry, Seema Naik, Amitkumar Mehta, Shazia K. Nakhoda, Stephen D Smith, Kathleen Dorritie, Ting Jia, Song Pham, Ling-Yuh Huw, Hao Wu, Iris To, Michael C. Wei, Julio C. Chavez
Journal: Blood
Blood (2023) 142 (Supplement 1): 613.
https://doi.org/10.1182/blood-2023-174209
Published: 2023
Journal Articles

Mosunetuzumab with Polatuzumab Vedotin Is Effective and Has a Manageable Safety Profile in Patients Aged <65 and ≥65 Years with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) and ≥1 Prior Therapy: Subgroup Analysis of a Phase Ib/II Study

Adam J. Olszewski, L. Elizabeth Budde, Julio Chavez, Nilanjan Ghosh, Manali Kamdar, Izidore S. Lossos, Catherine Diefenbach, Waleed Sabry, Kathleen Dorritie, Ling-Yuh Huw, Song Pham, Ting Jia, Hao Wu, Iris To, Michael C. Wei, Sarit Assouline
Journal: Blood
Blood (2022) 140 (Supplement 1): 3757–3759.
https://doi.org/10.1182/blood-2022-159594
Published: 2022
Journal Articles

Biosimilar G-CSF Versus Originator G-CSF for Autologous Peripheral Blood Stem Cell Mobilization: A Comparative Analysis of Mobilization and Engraftment

Julie Stakiw, MD FRCPC, Waleed Sabry, MSc, MD PhD, Mohamed Elemary, MD, Mark J. Bosch, MD, Pat Danyluk, Bsc. Pharm, Vibhuti Aggarwal, Bsc, Prosanta Mondal, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3345.
https://doi.org/10.1182/blood-2018-99-115341
Published: 2018
Journal Articles

The Impact from Frontline CLL Chemo Immunotherapy Regimen Outcomes Based on Patient Tolerability

Jake Towriss, Bsc, Prosanta Mondal, PhD, Waleed Sabry, MSc, MD PhD, Mohamed Elemary, MD, Hadi Alphonse Goubran, MD FACP, FRCP, Mark J. Bosch, MD, Julie Stakiw, MD FRCPC
Journal: Blood
Blood (2018) 132 (Supplement 1): 5551.
https://doi.org/10.1182/blood-2018-99-119462
Published: 2018
Journal Articles

Reduced Intensity Versus Myeloablative Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia

Donna Fan, MDcal Student, Waleed Sabry, MD MSc, PhD, Julie Stakiw, MD, Rebecca Ellyn MacKay, MD, Mark Bosch, MD FRCPC, Sabuj Sarker, Mohamed Elemary, MD MSc,PhD
Journal: Blood
Blood (2014) 124 (21): 5857.
https://doi.org/10.1182/blood.V124.21.5857.5857
Published: 2014
Journal Articles

Second Autologous Stem Cell Transplant As Salvage Therapy For Multiple Myeloma

Mohamed Elemary, MD, PhD., Mohamed Emara, MD, Ankur Sharma, MD, Sabuj Sarker, Waleed Sabry, MSc, MD, Julie Stakiw, MD
Journal: Blood
Blood (2013) 122 (21): 5529.
https://doi.org/10.1182/blood.V122.21.5529.5529
Published: 2013
Journal Articles

A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial

Clinical Trials & Observations
A. Keith Stewart, Suzanne Trudel, Nizar J. Bahlis, Darrell White, Waleed Sabry, Andrew Belch, Tony Reiman, Jean Roy, Chaim Shustik, Michael J. Kovacs, Morel Rubinger, Guy Cantin, Kevin Song, Kirsty A. Tompkins, Deb C. Marcellus, Martha Q. Lacy, Jonathan Sussman, Donna Reece, Michael Brundage, Erica L. Harnett, Lois Shepherd, Judy-Anne W. Chapman, Ralph M. Meyer
Journal: Blood
Blood (2013) 121 (9): 1517–1523.
https://doi.org/10.1182/blood-2012-09-451872
Published: 2013
Journal Articles

The Saskatchewan Experience for Using FCR in Treatment of CLL – A Comparison of Oral Versus IV Regimens

Richelle Dyck, Kathy Gesy, Waleed Sabry, MSc, MD, Mohamed Elemary, MD, PhD., David P. Sheridan, MD, Uthaman Moodley, MD, FRCPC, Kelsey Brose, MD, Julie Stakiw, MD
Journal: Blood
Blood (2011) 118 (21): 4613.
https://doi.org/10.1182/blood.V118.21.4613.4613
Published: 2011
Journal Articles

A Randomized Phase III Trial of Thalidomide and Prednisone as Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT) In Patients with Multiple Myeloma (MM): The NCIC CTG MY.10 Trial

A. Keith Stewart, Suzanne Trudel, MD, MSC, FRCPC, Nizar J Bahlis, MD, Darrell J White, MD, Waleed Sabry, MSc, MD, Andrew Belch, MD, Tony Reiman, MD, Jean Roy, MD, FRCPC, Chaim Shustik, MD, Michael J. Kovacs, MD, FRCPC, Jonathan Sussman, Ralph M. Meyer, MD, Erica L Harnett, M.Sc., Danila Oana, Judy A Chapman, Lois Shepherd, MD
Journal: Blood
Blood (2010) 116 (21): 39.
https://doi.org/10.1182/blood.V116.21.39.39
Published: 2010
Journal Articles

Tandem Autologous-Nonmyeloablative (NMA) Allogeneic(Allo) Transplant (Tx) in Newly Diagnosed Multiple Myeloma (MM) Leads to Improved Survival When Compared to Conventional Allogeneic Transplant

Waleed Sabry, Amelie Fontaine, MD, Richard Le Blanc, MD, PhD, Guy Sauvageau, Denis-Claude Roy, Lambert Busque, Sandra Cohen, Thomas Kiss, Silvy Lachance, Jean Roy
Journal: Blood
Blood (2008) 112 (11): 3299.
https://doi.org/10.1182/blood.V112.11.3299.3299
Published: 2008
Journal Articles

Graft-Versus-Host Disease (Gvhd) Prophylaxis with Tacrolimus and Mycophenolate Mofetil (MMF) in 131 Matched Sibling Nonmyeloablative (NMA) Transplant Recipients: Long-Term Follow-up Confirms Extremely Low Incidence of Acute (a) Gvhd, High Incidence of Extensive Chronic (c) Gvhd and Favorable Disease Outcome.

Waleed Sabry, Annie-Claude Labbé, Richard Le Blanc, MD, PhD, Guy Sauvageau, Denis-Claude Roy, Lambert Busque, Sandra Cohen, Thomas Kiss, Silvy Lachance, Jean Roy, MD
Journal: Blood
Blood (2008) 112 (11): 1176.
https://doi.org/10.1182/blood.V112.11.1176.1176
Published: 2008